.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The FSSAI recently issued a critical advisory regarding the inclusion of Withania somnifera in dietary products. This directive clarifies that manufacturers must prioritize Ashwagandha root extracts and roots in health supplements and nutraceuticals. Furthermore, the FSSAI emphasizes compliance with the 2016 regulations to ensure consumer safety across India.
Only certain plant parts are safe for human consumption according to Schedule IV of the 2016 regulations. Specifically, the advisory permits only the roots and Ashwagandha root extracts for use in nutraceuticals and functional foods. However, these ingredients must still adhere to prescribed limits and quality standards. Consequently, manufacturers must verify their raw materials to meet these strict legal requirements.
Recent reports indicated that some manufacturers were using Ashwagandha leaves or leaf extracts in their products. Consequently, the FSSAI explicitly stated that the use of leaves in any form is currently not permitted. This decision aligns with previous directives from the Ministry of Ayush, which also limited product formulations to roots. Therefore, any product containing leaf-based ingredients is now considered non-compliant under the Food Safety and Standards Act of 2006.
Food Business Operators (FBOs) must ensure their products align with these updated guidelines immediately. Furthermore, licensing authorities and food safety officers are now under instructions to maintain strict vigilance. Any observed deviation from these standards will lead to legal action. As a result, businesses should review their formulations to avoid penalties and ensure public health safety.
Q1: Which parts of Ashwagandha are allowed in food products?
Only the roots and Ashwagandha root extracts are permitted under current FSSAI regulations for health supplements and nutraceuticals.
Q2: Why are Ashwagandha leaves prohibited?
The FSSAI and Ministry of Ayush have not authorized the use of leaves in food products, focusing on the historical and safety data associated with the roots.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
FSSAI issues an advisory restricting Ashwagandha use in food products to roots and extracts only, prohibiting the use of leaves due to safety regulations....
4 months ago
A large NHANES cohort study reveals that higher Healthy Eating Index scores significantly reduce all-cause mortality risk in CKD patients by 45%. This analysis highlights the importance of comprehensive diet quality and medical nutrition therapy in renal care to optimize long-term clinical survival.
Today
A prospective cohort study demonstrates that poor adolescent sleep quality, especially long sleep latency and reduced efficiency, increases dysmenorrhea severity in young adulthood. Addressing adolescent rest patterns offers a critical preventive avenue for clinicians.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Today
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
